The impact of pathologic staging on the long‐term oncologic outcomes of patients with clinically high‐risk prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|11|1656-1662

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.11, 2014-06, pp. : 1656-1662

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long‐term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high‐risk prostate cancer

By  

BJU INTERNATIONAL, Vol. 116, Iss. 1, 2015-07 ,pp. : 50-56

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcomes for men with high‐risk prostate cancer treated definitively with external‐beam radiotherapy with or without androgen deprivation

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3260-3261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcomes for men with high‐risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3265-3271

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation

By  

Urologia Internationalis, Vol. 84, Iss. 2, 2010-03 ,pp. : 164-173

Karger

Access to resources Recommend Favorite

Oncologic Outcome of Radical Prostatectomy as Monotherapy for Men with High-risk Prostate Cancer

By  

Current Urology, Vol. 9, Iss. 2, 2016-05 ,pp. : 67-72

Karger

Access to resources Recommend Favorite